AVITA Medical, Inc.
RCELUS売上高
$72M
百万USD
営業利益
$-43M
百万USD
純利益
$-49M
百万USD
ROE
291.8%
最新FY
EPS
$-1.74
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $5M | $-10M | $-0.48 |
| FY2021 | Q2 | $5M | $-6M | $0.26 |
| FY2021 | Q3 | $9M | $-6M | $0.26 |
| FY2021 | FY | $29M | $-27M | $1.17 |
| FY2022 | Q1 | $8M | $-9M | $0.38 |
| FY2022 | Q2 | $8M | $-6M | $0.25 |
| FY2022 | Q3 | $9M | $-6M | $0.22 |
| FY2022 | FY | $34M | $-27M | $1.07 |
| FY2023 | Q1 | $11M | $-9M | $0.37 |
| FY2023 | Q2 | $12M | $-10M | $0.41 |
| FY2023 | Q3 | $14M | $-9M | $0.34 |
| FY2023 | FY | $50M | $-35M | $1.40 |
| FY2024 | Q1 | $11M | $-19M | $-0.73 |
| FY2024 | Q2 | $15M | $-15M | $-0.60 |
| FY2024 | Q3 | $20M | $-16M | $-0.62 |
| FY2024 | FY | $64M | $-62M | $-2.39 |
| FY2025 | Q1 | $19M | $-14M | $-0.53 |
| FY2025 | Q2 | $18M | $-10M | $-0.38 |
| FY2025 | Q3 | $17M | $-13M | $-0.46 |
| FY2025 | FY | $72M | $-49M | $-1.74 |
| FY2026 | Q1 | $19M | $-11M | $-0.35 |
財務データ
| 指標 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| 売上高 | $14M | $29M | $34M | $50M | $64M | $72M |
| 営業利益 | $-43M | $-27M | $-28M | $-43M | $-57M | $-43M |
| 純利益 | $-42M | $-27M | $-27M | $-35M | $-62M | $-49M |
| 総資産 | $82M | $126M | $98M | $112M | $80M | $56M |
| 純資産 | - | - | - | - | - | - |
| 自己資本 | $72M | $116M | $85M | $49M | $4M | $-17M |
| 営業CF | $-23M | $-26M | $-19M | $-38M | $-49M | $-31M |
| EPS | $2.07 | $1.17 | $1.07 | $1.40 | $-2.39 | $-1.74 |
| BPS | $3.37 | $4.65 | $3.35 | $1.91 | $0.17 | $-0.54 |
| ROE | -58.1% | -23.0% | -31.5% | -72.1% | -1374.6% | 291.8% |